hrp 112 has been researched along with medroxyprogesterone acetate in 63 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (9.52) | 18.7374 |
| 1990's | 36 (57.14) | 18.2507 |
| 2000's | 20 (31.75) | 29.6817 |
| 2010's | 1 (1.59) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Sayed, WS; Darwish, EA; el-Habashy, MA; Haiba, NA; Nayel, SE; Said, SA | 1 |
| Garza-Flores, J; Hall, PE; Koloszar, S; Konsayreepong, R; Kovacs, L; Perez-Palacios, G; Rodriguez, V; Tang-Keow, P; Virutamasen, P | 1 |
| Aedo, AR; Diczfalusy, E; Johannisson, E; Landgren, BM | 1 |
| Abdel-Rahman, A; Arce, B; Benagiano, G; Fotherby, K; Gual, C; Johannisson, E; Landgren, BM; Navaroli, F; Ramos-Cordero, R; Toppozada, HK | 1 |
| Chen, JK; Chen, SF; Fang, KJ; Ge, JL; Ge, RS; He, ML; Luo, SY; Sang, GW; Shao, QX; Song, S | 2 |
| Bassol, S; Hernandez, C; Luz de la Cruz, D; Nava, MP; Trujillo, AM | 1 |
| Toppozada, MK | 1 |
| Cookson, KM | 1 |
| Sang, GW | 1 |
| Koetsawang, S | 1 |
| el-Hussein, M; el-Nahal, N; Hassan, EO | 1 |
| Hall, PE | 2 |
| Fajans, P; Lubis, F; Simmons, R | 2 |
| d'Arcangues, C | 1 |
| Hadjar, LN; Pandi, SP; Prihyugiharto, T | 1 |
| Araujo, F; Bahamondes, L; de Lourdes Cristofoletti, M; Marchi, NM; Nakagava, HM; Pellini, E; Rubin, J | 1 |
| Cuong, DT; My Huong, NT | 1 |
| Bahamondes, L; Diaz, J; Lavín, P; Maradiegue, E; Monteiro, I; Ojeda, G; Petta, C | 1 |
| Bahamondes, L; Cristofoletti, Mde L; de Melo, ML; Marchi, NM; Nakagava, HM; Pellini, E; Petta, C; Scozzafave, RH | 1 |
| Bahamondes, L; Diaz, J; Hall, P; Petta, C | 2 |
| d'Arcangues, C; Dinchuen, P; Koetsawang, S; Patrasupapong, N; Piaggio, G; Pinol, A; Piya-Anant, M | 1 |
| Han, XJ; Sang, GW; Shao, QX; Weng, LJ; Zhou, XF | 1 |
| Alonso, A; Barrios, R; Cedeno, E; Ferman, JJ; Figueroa, JG; Fuziwara, JL; Garza-Flores, J; Guevara, SJ; Medina, LM; Monroy, J; Moraks del Olmo, A; Perez, M; Perez-Palacios, G; Urbina-Fuentes, M; Velazquez, E | 1 |
| Garza-Flores, J | 1 |
| el Houssinie, M; el Nahal, N; Hassan, EO | 1 |
| el-Hussinie, M; el-Nahal, N; Hassan, EO | 1 |
| Kaunitz, AM; Mishell, DR | 1 |
| Cromie, MA; Garceau, RJ; Kaunitz, AM | 1 |
| Rahimy, MH; Ryan, KK | 1 |
| Cromie, MA; Hopkins, NK; Rahimy, MH; Tong, DM | 1 |
| Hopkins, NK; Rahimy, MH; Ryan, KK | 1 |
| Oleen-Burkey, M; Shulman, LP; Willke, RJ | 1 |
| Cromie, MA; Maile, MH; Wajszczuk, CP | 1 |
| Arce, XE; Bahamondes, L; Diaz, J; Escanhoela, C; Maradiegue, E; Petta, C; Trelles, J | 1 |
| Jain, JK; Mishell, DR; Ota, F | 1 |
| Shulman, LP | 2 |
| Nelson, AL | 1 |
| Kaunitz, AM | 3 |
| Garceau, RJ; Kaunitz, AM; Wajszczuk, CJ | 1 |
| Wysocki, S | 1 |
| Alvarez-Sánchez, F; Bahamondes, L; Brache, V; Cook, LA; d'Arcangues, C; Hays, M; Hua, Y; Massai, R; Petta, CA; Salvatierra, A | 1 |
| Keder, LM | 1 |
| Gold, MA; Sucato, G | 1 |
| Freeman, S | 1 |
| Cockey, CD | 1 |
| Plourd, DM; Rayburn, WF | 1 |
| Bassol, S; Canto de Cetina, TE; Cetina Canto, JA; Luna, MO | 1 |
| Karanja, JG; Nasution, M; Nutley, T; Rivera, R; Ruminjo, JK; Sekadde-Kigondu, CB | 1 |
| Fraser, IS; Hashemi, Z; Simbar, M; Tehrani, FR; Zham, H | 1 |
| Archer, DF; Hall, P; Kimble, T; Schwartz, JL; Thurman, A | 1 |
14 review(s) available for hrp 112 and medroxyprogesterone acetate
| Article | Year |
|---|---|
Existing once-a-month combined injectable contraceptives.
Topics: Algestone Acetophenide; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Latin America; Medroxyprogesterone Acetate; Norethindrone | 1994 |
Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1994 |
Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Estradiol; Estrogen Antagonists; Estrogens, Conjugated (USP); Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; World Health Organization | 1993 |
New once-a-month injectable contraceptives, with particular reference to Cyclofem/Cyclo-Provera.
Topics: Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Drug Evaluation, Preclinical; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Patient Selection; Pregnancy; World Health Organization | 1998 |
Contraception 2000: lunelle, an injectable combination contraceptive option.
Topics: Contraceptive Agents, Female; Drug Administration Schedule; Drug Approval; Estradiol; Female; Fertility; Humans; Injections, Subcutaneous; Medroxyprogesterone Acetate; Menstrual Cycle | 2000 |
Clinical trial results with MPA/E2C.
Topics: Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Drug Administration Schedule; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; United States | 2000 |
Selecting a contraceptive method. Role of MPA/E2C.
Topics: Contraceptive Agents, Female; Decision Making; Drug Administration Schedule; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Patient Compliance; Women's Health | 2000 |
Injectable long-acting contraceptives.
Topics: Affect; Bone Density; Chemistry, Pharmaceutical; Contraceptive Agents, Female; Contraindications; Delayed-Action Preparations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Patient Education as Topic; Patient Selection; Pharmacoepidemiology; Risk Factors; United States; United States Food and Drug Administration; Weight Gain | 2001 |
Lunelle monthly injectable contraceptive. An effective, safe, and convenient new birth control option.
Topics: Contraception; Contraceptive Agents, Female; Drug Administration Schedule; Estradiol; Female; Fertility; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Patient Satisfaction; Pregnancy; Progesterone; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2001 |
Current options for injectable contraception in the United States.
Topics: Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Administration Schedule; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Pregnancy; Risk Factors; United States | 2001 |
New options in contraception for adolescents.
Topics: Adolescent; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Postcoital; Drug Administration Schedule; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Patient Education as Topic; Pregnancy; Pregnancy in Adolescence; Pregnancy, Unwanted; Sexual Behavior; United States | 2001 |
Contraceptive efficacy and patient acceptance of Lunelle.
Topics: Contraceptive Agents, Female; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Patient Acceptance of Health Care | 2002 |
New contraceptive methods.
Topics: Administration, Cutaneous; Contraception; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral; Estradiol; Female; Humans; Injections; Medroxyprogesterone Acetate | 2003 |
32 trial(s) available for hrp 112 and medroxyprogesterone acetate
| Article | Year |
|---|---|
Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Blood Proteins; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone | 1989 |
A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection. II. The comparison of bleeding patterns. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility
Topics: Amenorrhea; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1989 |
A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Ferti
Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Patient Compliance; Pregnancy; Random Allocation | 1988 |
A multicentered pharmacokinetic, pharmacodynamic study of once-a-month injectable contraceptives. I. Different doses of HRP112 and of DepoProvera. World Health Organization Task Force on Long-acting Systemic Agents for Fertility Regulation.
Topics: Adolescent; Adult; Cholesterol, HDL; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Random Allocation | 1987 |
A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone; Patient Dropouts | 1995 |
A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone | 1995 |
A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Estrone; Female; Glucuronates; Humans; Injections, Intramuscular; Kinetics; Medroxyprogesterone Acetate; Mexico; Norethindrone; Ovulation; Pregnanediol | 1995 |
Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
Topics: Attitude; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Egypt; Estradiol; Female; Humans; Marriage; Medroxyprogesterone Acetate; Norethindrone; Patient Satisfaction; Retrospective Studies; Surveys and Questionnaires | 1994 |
Maintaining technical quality of care in the introduction of Cyclofem in a national family planning program: findings from Indonesia.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraindications; Delayed-Action Preparations; Drug Combinations; Estradiol; Family Planning Services; Female; Humans; Indonesia; Injections; Medroxyprogesterone Acetate; Quality of Health Care | 1994 |
Introductory trial of the once-a-month injectable contraceptive, Cyclofem, in Indonesia.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Family Planning Services; Female; Humans; Indonesia; Injections; Life Tables; Medroxyprogesterone Acetate; Time Factors; World Health Organization | 1993 |
Uniject as a delivery system for the once-a-month injectable contraceptive Cyclofem in Brazil.
Topics: Anxiety; Brazil; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections; Medroxyprogesterone Acetate; Pain | 1996 |
Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and Cyclofem, in Vietnamese women.
Topics: Adult; Blood Pressure; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Life Tables; Longitudinal Studies; Medroxyprogesterone Acetate; Menstruation Disturbances; Multicenter Studies as Topic; Patient Dropouts; Patient Selection; Treatment Refusal; Uterine Hemorrhage; Vietnam | 1996 |
Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank,
Topics: Adult; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Follow-Up Studies; Humans; Injections; Lipids; Lipoproteins; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone; Triglycerides | 1997 |
Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru.
Topics: Adult; Amenorrhea; Brazil; Chile; Colombia; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Life Tables; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Dropouts; Peru; Pregnancy Rate | 1997 |
Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Topics: Adult; Amenorrhea; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Patient Dropouts; Progesterone Congeners; Time Factors; Uterine Hemorrhage | 1998 |
Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on glucose metabolism and liver function. United Nations Development Programme/United Population Fund/World Health Organization/World Bank, Sp
Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; gamma-Glutamyltransferase; Glucose Tolerance Test; Humans; Injections; Liver; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone | 1998 |
Introduction of cyclofem once-a-month injectable contraceptive in Mexico.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Educational Status; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Mexico; Patient Satisfaction; Prospective Studies | 1998 |
Cyclofem/Cyclo-Provera: emerging countries' perspective.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Developing Countries; Drug Combinations; Estradiol; Family Planning Services; Female; Health Knowledge, Attitudes, Practice; Humans; Injections, Intramuscular; Life Tables; Medroxyprogesterone Acetate; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Socioeconomic Factors | 1998 |
Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Egypt; Estradiol; Female; Humans; Injections, Intravenous; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; Weight Gain | 1999 |
Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lu
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Metrorrhagia; Norethindrone; Patient Compliance; Pregnancy; Weight Gain | 1999 |
Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics.
Topics: Adult; Arm; Body Mass Index; Body Weight; Contraceptive Agents, Female; Estradiol; Female; Hip; Humans; Injections, Intramuscular; Kinetics; Medroxyprogesterone Acetate; Thigh | 1999 |
Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): steady-state pharmacokinetics of MPA and E2 in surgically sterile women.
Topics: Absorption; Adult; Contraceptive Agents, Female; Estradiol; Female; Humans; Injections, Intramuscular; Kinetics; Medroxyprogesterone Acetate; Ovulation; Progesterone; Sterilization, Tubal | 1999 |
Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Patient Satisfaction; Surveys and Questionnaires | 1999 |
Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigator
Topics: Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Lipids; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Triglycerides | 2000 |
Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Ovarian Follicle; Prospective Studies; Ultrasonography | 2000 |
Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Norethindrone; Patient Compliance; Uterine Hemorrhage | 2000 |
Delayed first injection of the once-a-month injectable contraceptive containing 25 mg medroxyprogesterone acetate and 5 mg estradiol-cypionate: effects on cervical mucus.
Topics: Adult; Cervix Mucus; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Ovary; Sperm-Ovum Interactions; Time Factors | 2001 |
Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
Topics: Adolescent; Adult; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Factor VII; Factor X; Female; Fibrinogen; Fibrinolysis; Hemoglobins; Humans; Injections; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Partial Thromboplastin Time; Plasminogen; Plasminogen Inactivators; Platelet Count; Protein C; Prothrombin | 2003 |
Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections.
Topics: Adolescent; Adult; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Lipids; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Norethindrone | 2004 |
Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Satisfaction; Random Allocation; Surveys and Questionnaires | 2005 |
A comparative study of Cyclofem and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Endometrium; Estradiol; Female; Humans; Iran; Medroxyprogesterone Acetate | 2007 |
Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics.
Topics: Adult; Biological Availability; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Combinations; Drugs, Investigational; Estradiol; Female; Follow-Up Studies; Half-Life; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Metabolic Clearance Rate; Ovary; Ovulation Inhibition; Suspensions | 2013 |
17 other study(ies) available for hrp 112 and medroxyprogesterone acetate
| Article | Year |
|---|---|
Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations.
Topics: Adult; Biopsy; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Endometrium; Estradiol; Female; Humans; Injections; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Ovulation; Progesterone | 1985 |
A preliminary pharmacological trial of the monthly injectable contraceptive cycloprovera.
Topics: Adult; Biopsy; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Endometrium; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Ovarian Follicle; Ovulation | 1982 |
The parenteral toxicity of Cyclofem.
Topics: Adenocarcinoma; Animals; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Injections, Intramuscular; Injections, Intraperitoneal; Injections, Subcutaneous; Macaca mulatta; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred ICR; Pituitary Neoplasms; Rabbits; Rats | 1994 |
The introduction of Cyclofem into national family planning programmes: experience from studies in Indonesia, Jamaica, Mexico, Thailand and Tunisia. Task Force on Research on Introduction and Transfer of Technologies for Fertility Regulation, Special Progr
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Family Planning Services; Female; Humans; Indonesia; Injections; Jamaica; Medroxyprogesterone Acetate; Mexico; Patient Satisfaction; Pilot Projects; Pregnancy; Thailand; Tunisia; World Health Organization | 1994 |
Contraceptive introduction and the management of choice: the role of Cyclofem in Indonesia.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Delivery of Health Care; Drug Combinations; Estradiol; Family Planning Services; Female; Humans; Indonesia; Injections; Medroxyprogesterone Acetate | 1994 |
Once-a-month injectable contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone | 1993 |
Return of fertility after discontinuation of the once-a-month injectable contraceptive Cyclofem.
Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Fertility; Humans; Injections; Medroxyprogesterone Acetate; Pregnancy; Time Factors | 1997 |
Self-administration with UniJect of the once-a-month injectable contraceptive Cyclofem.
Topics: Brazil; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Evaluation Studies as Topic; Female; Humans; Injections; Medroxyprogesterone Acetate; Patient Satisfaction; Self Administration; Time Factors | 1997 |
Pharmacokinetics of medroxyprogesterone acetate after single and multiple injection of Cyclofem in Chinese women.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Kinetics; Medroxyprogesterone Acetate | 1998 |
Weight variation in users of the once-a-month injectable contraceptive Cyclofem.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Menstrual Cycle; Weight Gain | 1998 |
Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Counseling; Drug Combinations; Egypt; Estradiol; Female; Focus Groups; Humans; Islam; Medroxyprogesterone Acetate; Norethindrone; Patient Satisfaction; Social Support | 1999 |
Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): a contraceptive method for women in the US and worldwide.
Topics: Contraceptive Agents, Female; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate | 1999 |
Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women.
Topics: Contraceptive Agents, Female; Estradiol; Female; Humans; Injections, Intramuscular; Kinetics; Medroxyprogesterone Acetate; Ovulation; Progesterone; Sterilization, Tubal | 1999 |
Endometrial histology in long-term users of the once-a-month injectable contraceptive Cyclofem.
Topics: Adult; Biopsy; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Endometrium; Estradiol; Female; Humans; Medroxyprogesterone Acetate | 1999 |
Lunelle: a new contraceptive alternative.
Topics: Contraceptive Agents, Female; Estradiol; Female; Humans; Medroxyprogesterone Acetate | 2001 |
New developments in contraception.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Estradiol; Female; Forecasting; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Vinyl Compounds | 2002 |
Injectable Lunelle contraceptive being recalled.
Topics: Contraceptive Agents, Female; Drug and Narcotic Control; Estradiol; Humans; Medroxyprogesterone Acetate; Puerto Rico; United States; United States Virgin Islands | 2002 |